Because semaglutide clears gradually, the transition period doesn't trigger abrupt appetite rebound
This modification facilitates non-covalent binding to serum albumin, which dramatically extends the peptide's pharmacokinetic half-life, making it suitable for less frequent administration in longitudinal research studies
Normal poop can say a lot about your health status
Making Meals Work: A Practical Meal Plan Guide for Life on Semaglutide GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) change the way your body responds to food less hunger, earlier fullness, slower digestion, and a completely different relationship with eating
In our July 2025 analysis, The Semaglutide Story: Highlighting the Need to Maintain Patent Protection in Canada, we examined the vulnerabilities exposed by the lapse of Novo Nordisks core compound patent (CA 2,601,784) for semaglutidethe active ingredient in blockbuster drugs Ozempic and Wegovy